drugset / Trial / NCT00002677
Tributyrin in Treating Patients With Refractory Prostate Cancer or Other Solid Tumors
Phase 1
Completed
24 enrolled
University of Maryland, Baltimore
National Cancer Institute (NCI) · collab
NaSingle-groupOpen-labelTreatment
Summary
Phase I trial to study the effectiveness of tributyrin in treating patients with refractory stage IV prostate cancer or other solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.
Timeline
- Start
- 1995-08
- Primary completion
- 2003-03
- Completion
- 2003-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | tributyrin | Other / unclassified | — | Oral |